Opinion: [Withdrawal of Rimonabant - Walking the Tightrope of 21st Century Pharmaceutical Regulation?]

Author: Taylor, David

Source: Current Drug Safety, Volume 4, Number 1, January 2009 , pp. 2-4(3)

Publisher: Bentham Science Publishers

Abstract:

Document Type: Research article

DOI: http://dx.doi.org/10.2174/157488609787354396

Publication date: 2009-01-01

• Current Drug Safety publishes frontier reviews on all the latest advances on drug safety. The journal's aim is to publish the highest quality review articles in the field. Topics covered include: adverse effects of individual drugs and drug classes, management of adverse effects, pharmacovigilance and pharmacoepidemiology of new and existing drugs, post-marketing surveillance. The journal is essential reading for all researchers and clinicians involved in drug safety.

• In this: publication
• By this: publisher
• In this Subject: Pharmacology
• By this author: Taylor, David

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers